Literature DB >> 3158266

Occurrence of neuropathological changes and dementia of Alzheimer's disease in Down's syndrome.

K E Wisniewski, H M Wisniewski, G Y Wen.   

Abstract

One hundred brains of patients with Down's syndrome (DS) who died in institutions for chronic care were examined for clinicopathological correlation of Alzheimer's disease. Fifty-one were below and 49 were above age 30 years at death. Tissues from the right, prefrontal, and hippocampal cortices were processed for microscopy using H&E and Bodian-periodic acid-Schiff impregnation. Morphometric evaluations of plaques and tangles were carried out. Plaques or plaques and tangles were found in the brains of 56 patients with DS, 7 below age 30 and 49 above that age. A history of dementia was evident in the medical records of 15 of these patients; of these only 2 were below the age of 30. The brains of the patients with DS who also had clinical dementia had more than twenty plaques or plaques and tangles per 1.5 X 10(6) micron 2 of cortex. The numbers of plaques and tangles found in the brains of the patients with DS above the age of 30 greatly increased with age but varied from brain to brain. These observations suggest a correlation among dementia, the density of plaques and tangles, and age. All 100 brains studied showed early arrest of brain growth and brain atrophy, a condition that may have been due to prenatal arrest of neurogenesis mainly in the granular cell layers, prenatal and postnatal arrest of synaptogenesis, and early aging. Plaques and tangles developed twenty to thirty years earlier and dementia was clinically detected at least three times more frequently (20 to 30%) in DS than it is known to occur in the non-DS population.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3158266     DOI: 10.1002/ana.410170310

Source DB:  PubMed          Journal:  Ann Neurol        ISSN: 0364-5134            Impact factor:   10.422


  272 in total

Review 1.  The pervasiveness of interleukin-1 in alzheimer pathogenesis: a role for specific polymorphisms in disease risk.

Authors:  W S Griffin; J A Nicoll; L M Grimaldi; J G Sheng; R E Mrak
Journal:  Exp Gerontol       Date:  2000-07       Impact factor: 4.032

2.  Probing peripheral and central cholinergic system responses.

Authors:  C A Naranjo; J Fourie; N Herrmann; K L Lanctôt; C Birt; K K Yau
Journal:  J Psychiatry Neurosci       Date:  2000-09       Impact factor: 6.186

3.  Dementia diagnostic criteria in Down syndrome.

Authors:  Rory Sheehan; Amanda Sinai; Nick Bass; Pippa Blatchford; Ingrid Bohnen; Simon Bonell; Ken Courtenay; Angela Hassiotis; Therese Markar; Jane McCarthy; Kamalika Mukherji; Asim Naeem; Dimitrios Paschos; Natalia Perez-Achiaga; Vijaya Sharma; David Thomas; Zuzana Walker; Andre Strydom
Journal:  Int J Geriatr Psychiatry       Date:  2014-11-03       Impact factor: 3.485

4.  Neuroinflammatory Cytokines-The Common Thread in Alzheimer's Pathogenesis.

Authors:  W Sue T Griffin; Steven W Barger
Journal:  US Neurol       Date:  2010

Review 5.  MicroRNA dysregulation in neuropsychiatric disorders and cognitive dysfunction.

Authors:  Bin Xu; Pei-Ken Hsu; Maria Karayiorgou; Joseph A Gogos
Journal:  Neurobiol Dis       Date:  2012-03-03       Impact factor: 5.996

6.  Primary biliary cirrhosis and systemic amyloidosis, a new association.

Authors:  Hector Rodriguez-Luna; Hugo E Vargas; James Williams; Giovanni De Petris; Jorge Rakela; David D Douglas
Journal:  Dig Dis Sci       Date:  2004-08       Impact factor: 3.199

7.  Working memory in the aged Ts65Dn mouse, a model for Down syndrome.

Authors:  Katharine N Whitney; Galen R Wenger
Journal:  Behav Brain Res       Date:  2012-04-04       Impact factor: 3.332

8.  Perinatal choline supplementation improves cognitive functioning and emotion regulation in the Ts65Dn mouse model of Down syndrome.

Authors:  Jisook Moon; May Chen; Shruti U Gandhy; Myla Strawderman; David A Levitsky; Kenneth N Maclean; Barbara J Strupp
Journal:  Behav Neurosci       Date:  2010-06       Impact factor: 1.912

9.  Frontal white matter integrity in adults with Down syndrome with and without dementia.

Authors:  David Powell; Allison Caban-Holt; Gregory Jicha; William Robertson; Roberta Davis; Brian T Gold; Frederick A Schmitt; Elizabeth Head
Journal:  Neurobiol Aging       Date:  2014-02-04       Impact factor: 4.673

10.  Truncation and Activation of Dual Specificity Tyrosine Phosphorylation-regulated Kinase 1A by Calpain I: A MOLECULAR MECHANISM LINKED TO TAU PATHOLOGY IN ALZHEIMER DISEASE.

Authors:  Nana Jin; Xiaomin Yin; Jianlan Gu; Xinhua Zhang; Jianhua Shi; Wei Qian; Yuhua Ji; Maohong Cao; Xiaosong Gu; Fei Ding; Khalid Iqbal; Cheng-Xin Gong; Fei Liu
Journal:  J Biol Chem       Date:  2015-04-27       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.